Table of Contents Table of Contents
Previous Page  564 / 1631 Next Page
Information
Show Menu
Previous Page 564 / 1631 Next Page
Page Background

Idelalisib: Selective PI3K Inhibitor :Tumour Response

Gopal A, et al. NEJM 2014